Exabis Library
Welcome to the e-CCO Library!
P684: Vaccination strategies for IBD patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P685 Healthcare resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
Wednesday, 3 March 2021, 4:11 PM by Dauren Ramankulov
P685: Early use of infliximab after seton technique for patients with Crohn's disease who initially presented with perianal fistulas
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P685: Gut microbiota in patients with Inflammatory Bowel Disease during remission
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P685: Improvement in patient-reported Inflammatory Bowel Disease Questionnaire outcomes, and relationship with disease activity, in tofacitinib-treated patients with ulcerative colitis: Data from the OCTAVE clinical trials
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P685: Patient’s performance and feedback by using home test faecal calprotectin as an objective reported outcome
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P685: Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P685: Switching from originator-infliximab to biosimilar-infliximab has no influence on health-related quality of life and clinical disease activity among patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P686 Expression of CD39 ectonucleotidase on regulatory T cells and on T helper 17 cells in children with IBD receiving anti-TNF therapy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P686: Application of dried blood spots for pharmacokinetic profiling of golimumab-treated patients with ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P686: Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn’s disease patients: PRACTICROHN study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P686: Neither high infliximab maintenance doses nor high trough levels trigger skin side effects of the drug: a prospective cross-sectional study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P686: Novel grape-derived prebiotic selectively enhances abundance and metabolic activity of IBD and IBS faecal butyrate producing bacteria in an in vitro model of intestinal fermentation
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P686: Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P687 Early and sustained improvement in stool frequency and rectal bleeding following 52 weeks of mirikizumab treatment
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P687: Clinical remission demonstrated with oral ozanimod in the overall population and across multiple subgroups of patients with moderately to severely active ulcerative colitis in the TOUCHSTONE trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P687: Development of a panel of microbial markers to distinguish transient from pathological dysbiosis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P687: Durability of recaptured response to ozanimod during the True North open-label extension
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P687: Fate of the rectum in anorectal Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P687: Female sex is associated with discontinuation of subcutaneous anti-TNF therapy for side effects in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM